Flora (NASDAQ: FLGC), a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution, has announced its entry into a partnership with TruHC Pharma, a medical cannabis expert based in Hamburg, Germany. TruHC holds an EU-GDP certification as an importer, distributor and manufacturer of medical cannabis, and operates a production facility with a cutting-edge cannabis laboratory for which an EU-GMP license is expected by the end of September. Hendrik Knopp, a respected lawyer, accomplished entrepreneur and leader who has been pivotal in establishing Germany’s medical cannabis landscape, along with the TruHC team, join the Flora family. “I am delighted to welcome Hendrik Knopp and the TruHC team to the Flora group. Their expertise and achievements within the industry, particularly in pioneering medical cannabis in Germany, make them invaluable partners,” said Clifford Starke, chief executive officer of Flora. “We are poised to execute our strategic business plan and capture a meaningful market share in Germany.”
To view the full press release, visit https://ibn.fm/1u63q
About Flora Growth Corp.
Flora is a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution. For more information on Flora, visit www.FloraGrowth.com.
NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork
